Volume | 1,087,749 |
|
|||||
News | (1) | ||||||
Day High | 23.29 | Low High |
|||||
Day Low | 22.045 |
Company Name | Stock Ticker Symbol | Market | Type |
---|---|---|---|
Corcept Therapeutics Inc | CORT | NASDAQ | Common Stock |
Open Price | Low Price | High Price | Close Price | Prev Close |
---|---|---|---|---|
23.00 | 22.045 | 23.29 | 22.48 | 23.00 |
Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
---|---|---|---|---|---|
15,248 | 1,087,749 | $ 22.39 | $ 24,349,891 | - | 20.84 - 34.275 |
Last Trade Time | Type | Quantity | Stock Price | Currency |
---|---|---|---|---|
16:11:30 | 1 | $ 22.48 | USD |
Corcept Therapeutics (CORT) Options Flow Summary
Corcept Therapeutics Inc Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
2.33B | 103.52M | - | 482.38M | 106.14M | 1.03 | 21.93 |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
Corcept Therapeutics News
Loading Messages....
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical CORT Price Data
Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 23.52 | 24.23 | 20.84 | 22.64 | 1,727,380 | -1.04 | -4.42% |
1 Month | 24.89 | 26.10 | 20.84 | 23.77 | 1,009,158 | -2.41 | -9.68% |
3 Months | 22.00 | 26.10 | 20.84 | 23.36 | 1,112,167 | 0.48 | 2.18% |
6 Months | 27.47 | 33.28 | 20.84 | 24.58 | 1,201,488 | -4.99 | -18.17% |
1 Year | 22.46 | 34.275 | 20.84 | 25.44 | 935,264 | 0.02 | 0.09% |
3 Years | 24.15 | 34.275 | 15.825 | 23.16 | 870,870 | -1.67 | -6.92% |
5 Years | 12.29 | 34.275 | 9.55 | 20.17 | 958,518 | 10.19 | 82.91% |
Corcept Therapeutics Description
Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic and neuropsychiatric disorders by modulating the effect of the hormone cortisol. |